FDA PRODUCT CODE · CLASS II

PKL — Hemostatic Metal Clip For The Gi Tract

Clip placement within the gastrointestinal (GI) tract for the purpose of endoscopic marking, hemostasis for mucosal/sub-mucosal defects, bleeding ulcers, arteries, polyps, diverticula in the colon, prophylactic clipping, anchoring feeding tubes, supplemental closure method of luminal perforations.

What these counts are not

Clearance and recall counts are SPEQ’s aggregation of FDA’s own published records for the code. A recall count is a measure of history, not of a device’s safety, neither number is an FDA rating, and SPEQ is not affiliated with the FDA.

DEVICE CLASS
Class II
REGULATION
21 CFR 876.4400
MEDICAL SPECIALTY
Gastroenterology, Urology
REVIEW PANEL
GU
✓ Implant✓ Life-sustaining— GMP-exempt— Third-party review eligible
13
510(K)/PMA CLEARANCES
510k: 13
1
RECALL ENTRIES

What this classification requires

Every statement below is FDA’s own classification record for this product code, quoted from the device classification field reference. The SPEQ reading beneath each one is SPEQ’s interpretation of what it means for the work, and is not FDA text.

PREMARKET PATHWAY

510(K)

SPEQ READINGA premarket notification under 21 CFR Part 807 Subpart E is the route for this code. The submission argues substantial equivalence to a legally marketed predicate, so the engineering question is which predicate the design can actually be compared against, and the evidence question is what testing supports that comparison.

DEVICE CLASS

Class II (moderate to high risk): general controls and special controls

SPEQ READINGSpecial controls are the distinguishing feature: performance standards, guidance documents, patient registries or postmarket surveillance named for the device type. Find the special controls before designing the test plan — they usually name the tests.

MALFUNCTION REPORTING

Device is not eligible for The Voluntary Malfunction Summary Reporting Program

SPEQ READINGIndividual malfunction reporting under 21 CFR Part 803 applies. The complaint-handling system has to produce a decision per event, not per period.

GMP / QUALITY SYSTEM

Not exempt due to Good Manufacturing Practice (GMP)/Quality System

SPEQ READINGThe full Quality Management System Regulation (21 CFR 820, incorporating ISO 13485:2016) applies, and is what an FDA inspection of this device will be conducted against.

IMPLANT

Device is implantable

SPEQ READINGImplant status raises the evidentiary bar on biocompatibility and on traceability from finished device back to material lot.

LIFE-SUSTAINING

Device is used for life sustaining purposes.

SPEQ READINGA life-sustaining designation is what brings device tracking under 21 CFR Part 821 into scope, and it raises what a risk file has to say about single-fault conditions.

THIRD-PARTY REVIEW

Device is not a candidate for a third party review program

SPEQ READINGFDA reviews any premarket notification for this code directly.

Other product codes under 21 CFR 876.4400

One regulation usually governs several product codes. These share this code’s regulation, and therefore its classification basis.

21 CFR 876.4400 — Hemorrhoidal ligator

The classification regulation for this product code, as published by the Office of the Federal Register. This is the regulation text itself — no SPEQ interpretation appears in it.

(a) Identification. A hemorrhoidal ligator is a device used to cut off the blood flow to hemorrhoidal tissue by means of a ligature or band placed around the hemorrhoid.

(b) Classification. Class II (special controls). Except for a hemostatic metal clip intended for use in the gastrointestinal tract, the device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9. [48 FR 53023, Nov. 23, 1983, as amended at 84 FR 71813, Dec. 30, 2019]

Source: Electronic Code of Federal Regulations, Title 21. 21 CFR is a work of the United States Government and is in the public domain. SPEQ read this section on October 22, 2026. CFR is amended continuously, so verify against the source before acting on it: read 21 CFR 876.4400 on eCFR →

Recent clearances

K261741Anrei Medical (Hz) Co., Ltd. · 510k2026-10-02
K260487Ovesco Endoscopy AG · 510k2026-10-02
K253481Ovesco Endoscopy AG · 510k2026-09-14
K254069Hangzhou AGS MedTech Co., Ltd. · 510k2026-08-10
K260580Olympus Medical Systems Corp. · 510k2026-05-21
K252270Hangzhou AGS MedTech Co., Ltd. · 510k2026-04-08
K253734Taurus Endoscopy · 510k2026-03-12
K251562Ovesco Endoscopy AG · 510k2025-12-18

Recent recalls

US Endoscopy Group IncTerminated

Potential esophageal laceration during a patient procedure

Source: FDA device classification, 510(k)/PMA, and recall datasets. Recall entries count distinct FDA recall numbers, so one recall event affecting several products appears as several entries. Browse every product code SPEQ tracks →